OTC:ANEB | Cash Flow Statement | Anebulo Pharmaceuticals, Inc.

Complete source-backed cash-flow history.

Available history
2020-09-30 to 2025-12-31
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$2M
2025-09-30-$2.16M-$1.27M
2025-06-30-$2.14M-$1.65M$0.00
2025-03-31-$1.68M
2024-12-31-$2.46M
2024-09-30-$2.2M-$1.69M
2024-06-30-$1.35M-$2.05M$0.00
2024-03-31-$1.65M
2023-12-31-$2.72M
2023-09-30-$2.48M-$2.73M
2023-06-30-$2.5M-$2.85M-$68,156.00
2023-03-31-$2.8M
2022-12-31-$3.83M
2022-09-30-$2.61M-$2.03M$6.7M
2022-06-30-$2.32M-$2M
2022-03-31-$1.88M
2021-12-31-$1.07M
2021-09-30-$1.55M-$777,902.00
2021-06-30-$29.11M-$3.5M$20.18M
2021-03-31-$555,832.00
2020-12-31-$328,604.00
2020-09-30-$256,379.00-$134,956.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-06-30-$8.48M-$6.35M$14.88M
2024-06-30-$8.2M-$8.09M-$62,354.00
2023-06-30-$11.73M-$9.68M$6.38M
2022-06-30-$6.83M-$5.44M
2021-06-30-$30.25M-$4.87M$21.83M